← Calendar
Readoutin 14d
Viatris Innovation GmbH — Cenerimod
Phase 3 primary completion: A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Lupus Erythematosus, Systemic
Source ↗Add to calendar
Get told when this date moves
The weekly brief is free. Pro adds reminders 7 days and 1 day before.
More from Viatris Innovation GmbH
Mar2027
Readoutin 104d
Viatris Innovation GmbH — CenerimodPhase 3 primary completion: A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus.